Nav: Home

Novel target for diabetes drug identified as ion exchanger

October 13, 2016

Nagoya, Japan - The most common type of diabetes, type 2, is characterized by insulin resistance and high blood glucose. Many patients are prescribed metformin, an anti-diabetic drug known to decrease hepatic glucose production and increase its uptake by muscle. Metformin also shows positive effects on other diseases such as polycystic ovary syndrome, nerve disorders, and some cancers. These versatile effects suggest that metformin could target multiple molecules, although details of its targets have remained unclear. A research team led by Nagoya University has now identified a novel potential target, a protein that mediates the exchange of sodium and hydrogen ions, using the model nematode Caenorhabditis elegans. The study was reported in the Journal of Biological Chemistry.

This latest study found that metformin reduces L1 longevity, a survival response to starvation of the first larval stage, in C. elegans. A genetic screen identified a mutant worm resistant to metformin's action. The mutation was mapped to the endosomal sodium/hydrogen exchanger protein NHX-5, suggesting it could be used as a potential target.

The fruit fly Drosophila is another model organism that researchers commonly use, and it was previously shown that metformin treatment reduces the lifespan of flies. In this study, the researchers tested mutant flies lacking NHE3, which is the homologous protein (one sharing an evolutionary history) to NHX-5 in Drosophila. They showed that NHE3 mutant flies are completely resistant to metformin. This result suggests that NHE is also the target of metformin in flies and that NHE may be a conserved target of metformin in other species.

NHX-5 is expressed in many parts of C. elegans, including the intestine and neurons. In the cell, it exists in the membranes of cellular components known as endosomes. Endosomes transport molecules such as proteins through a pathway that enables the sorted proteins to be secreted, recycled, or degraded. Treatment of C. elegans with metformin was shown to prevent formation of related cellular components known as autophagosomes, which are structures that break down cellular material, particularly during periods of starvation as a means of obtaining energy.

Metformin also reduced the oxygen consumption rate of C. elegans, hinting it may inhibit the function of mitochondria (cellular metabolic energy generators), as seen in mammals. "These findings suggest metformin targets NHX-5 to disrupt autophagy and related subcellular processes during L1 starvation in C. elegans, so that less energy is available," corresponding author Young-Jai You says. "This ultimately reduces L1 longevity, and supports a link between mitochondria and the endocytic cycle that is controlled by NHX-5."

This work offers new insight into the molecular mechanism of metformin action, which could aid development of new treatments for diabetes.
The article, "NHX-5, an Endosomal Na+/H+ Exchanger, Is Associated with Metformin Action" was published in the Journal of Biological Chemistry at DOI:10.1074/jbc.C116.744037

Nagoya University

Related Diabetes Articles:

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.
Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.
Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).
Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.
People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.
Diabetes, but not diabetes drug, linked to poor pregnancy outcomes
New research indicates that pregnant women with pre-gestational diabetes who take metformin are at a higher risk for adverse pregnancy outcomes -- such as major birth defects and pregnancy loss -- than the general population, but their increased risk is not due to metformin but diabetes.
New oral diabetes drug shows promise in phase 3 trial for patients with type 1 diabetes
A University of Colorado Anschutz Medical Campus study finds sotagliflozin helps control glucose and reduces the need for insulin in patients with type 1 diabetes.
Can continuous glucose monitoring improve diabetes control in patients with type 1 diabetes who inject insulin
Two studies in the Jan. 24/31 issue of JAMA find that use of a sensor implanted under the skin that continuously monitors glucose levels resulted in improved levels in patients with type 1 diabetes who inject insulin multiple times a day, compared to conventional treatment.
Complications of type 2 diabetes affect quality of life, care can lead to diabetes burnout
T2D Lifestyle, a national survey by Health Union of more than 400 individuals experiencing type 2 diabetes (T2D), reveals that patients not only struggle with commonly understood complications, but also numerous lesser known ones that people do not associate with diabetes.
A better way to predict diabetes
An international team of researchers has discovered a simple, accurate new way to predict which women with gestational diabetes will develop type 2 diabetes after delivery.
More Diabetes News and Diabetes Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Making Amends
What makes a true apology? What does it mean to make amends for past mistakes? This hour, TED speakers explore how repairing the wrongs of the past is the first step toward healing for the future. Guests include historian and preservationist Brent Leggs, law professor Martha Minow, librarian Dawn Wacek, and playwright V (formerly Eve Ensler).
Now Playing: Science for the People

#566 Is Your Gut Leaking?
This week we're busting the human gut wide open with Dr. Alessio Fasano from the Center for Celiac Research and Treatment at Massachusetts General Hospital. Join host Anika Hazra for our discussion separating fact from fiction on the controversial topic of leaky gut syndrome. We cover everything from what causes a leaky gut to interpreting the results of a gut microbiome test! Related links: Center for Celiac Research and Treatment website and their YouTube channel
Now Playing: Radiolab

The Flag and the Fury
How do you actually make change in the world? For 126 years, Mississippi has had the Confederate battle flag on their state flag, and they were the last state in the nation where that emblem remained "officially" flying.  A few days ago, that flag came down. A few days before that, it coming down would have seemed impossible. We dive into the story behind this de-flagging: a journey involving a clash of histories, designs, families, and even cheerleading. This show is a collaboration with OSM Audio. Kiese Laymon's memoir Heavy is here. And the Hospitality Flag webpage is here.